Fast Track Total Knee Arthroplasty: Local Infiltration Analgesia vs Femoral Nerve Block (NCT01966263) | Clinical Trial Compass
CompletedPhase 4
Fast Track Total Knee Arthroplasty: Local Infiltration Analgesia vs Femoral Nerve Block
Netherlands80 participantsStarted 2013-11
Plain-language summary
The objective of this study is to determine whether either a femoral nerve block (FNB) or local infiltration analgesia (LIA) is a better anesthetic technique to achieve optimal functional outcome after one year in patients receiving a total knee arthroplasty and following a fast track rehabilitation protocol.
Who can participate
Age range50 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* American Society of Anesthesiologists (ASA) physical health status I-II
* patient presents with non-inflammatory primary knee osteoarthritis (radiological confirmation)
* patient is planned for a primary unilateral posterior-stabilized tri-compartmental cemented total knee replacement (Genesis II - PS)
* patient is scheduled for fast track protocol
* patient plans to be available fot follow-up through one year post-operative
* written informed consent
Exclusion Criteria:
* any contra-indication for locoregional anesthesia
* any contra-indication for spinal anesthesia
* traumatic osteoarthritis requiring TKA
* an active, local infection or systemic infection
* known hypersensitivity to amide-type local anesthetics
* known intolerance or contraindication for opioids, nonsteroidal antiinflammatory drugs (NSAIDs) or paracetamol
* a Body Mass Index \> 40 kg/m2
* inability to walk independently (inability to walk at least 10 consecutive meters without a walking aid)
* scheduled for contralateral TKA within one year postoperative
* scheduled for another operation within 3 months postoperative
* physical, emotional or neurological conditions that would compromize compliance with postoperative rehabilitation and follow-up
* chronic opioid analgesic therapy
* chronic gabapentin or pregabalin analgesic therapy
* rheumatoid arthritis